SCA: SCA’s Divestments of Former Georgia-Pacific Units Approved
STOCKHOLM -- April 19, 2013
In conjunction with SCA’s (STO:SCAA) (STO:SCAB) acquisition of
Georgia-Pacific’s European tissue operations during the summer of 2012, the EU
Commission imposed requirements concerning the divestment of certain units
within consumer tissue. This was communicated in a press release on July 19,
2012. The EU Commission has now approved the divestments.
The requirements imposed by the EU Commission included the sale of parts of
Georgia-Pacific’s former operations in the UK, Ireland and the Benelux
countries, and certain operations in the Scandinavian region.
The branded business in the UK, Ireland and the Benelux countries is being
sold to Sofidel. The production facility in Horwich, UK, is included in this
The retailer brand businesses in the UK and Ireland are being sold to
Northwood & WEPA. The production facility in Bridgend, UK, is included in this
Parts of the Nordic retailer brand business have been sold to Vajda Papir. The
production facility in Drammen, Norway is included in the transaction,
together with a conversion line from the facility in Nokia, Finland.
These operations together represent total sales of about EUR 200m and the
combined purchase consideration is approximately EUR 100m.
SCA is a leading global hygiene and forest products company. The Group
develops and produces sustainable personal care, tissue and forest products.
Sales are conducted in about 100 countries under many strong brands, including
the leading global brands TENA and Tork, and regional brands, such as Lotus,
Libresse, Tempo and Libero. As Europe’s largest private forest owner, SCA
places considerable emphasis on sustainable forest management. The Group has
about 36,000 employees and sales in 2012 amounted to SEK 85bn (EUR 9.8bn). SCA
was founded in 1929, has its headquarters in Stockholm, Sweden, and is listed
on NASDAQ OMX Stockholm. For more information, visit www.sca.com.
This information was brought to you by Cision http://news.cision.com
VP Investor Relations
+46 8 788 51 30
Press & Media Officer
+46 8 788 53 62
Press spacebar to pause and continue. Press esc to stop.